Regulatory considerations for marker vaccines and diagnostic tests in the U.S.

Biologicals

Volumn 33, Issue 4, 2005, Pages 253-256

  Foley, Patricia L ^a   Hill Jr , Richard E ^a  

^a UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Diagnostic; Disease; Licensing; Marker; Regulatory; Vaccine; Veterinary

Indexed keywords

DNA VACCINE; INFLUENZA VACCINE; MARKER VACCINE; PSEUDORABIES VACCINE; RABIES VACCINE; RECOMBINANT DNA; SUBUNIT VACCINE; VIRUS VECTOR;

ARTICLE; BIOTECHNOLOGY; DIAGNOSTIC TEST; DISEASE CONTROL; GENETIC ENGINEERING; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PSEUDORABIES; PSEUDORABIES HERPETOVIRUS; RISK ASSESSMENT; UNITED STATES; VACCINATION; VACCINIA VIRUS; VETERINARY MEDICINE;

ANIMAL DISEASES; ANIMALS; BIOTECHNOLOGY; DIAGNOSTIC TESTS, ROUTINE; DRUG APPROVAL; LEGISLATION, DRUG; LEGISLATION, VETERINARY; LICENSURE; QUALITY CONTROL; UNITED STATES; VACCINATION; VACCINES, MARKER;

ANIMALIA; SUID HERPESVIRUS 1; SUS SCROFA; VACCINIA VIRUS;

EID: 28544449443     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2005.08.010     Document Type: Article

References (16)

1. T.C. Mettenleiter Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis - state of the art, June 1999 Vet Res 31 2000 99 115
2. R.E. Hill, P.L. Foley, M.Y. Carr, L.A. Elsken, D. Gatewood, and L.R. Ludemann Regulatory considerations for emergency use of non-USDA licensed vaccines in the United States F. Brown J. Roth Vaccines for OIE list A and emerging animal diseases Dev Biol 114 2003 31 52
3. D.E. Roscoe, W.C. Holste, F.E. Sorhage, C. Campbell, M. Niezgoda, and R. Buchannan Efficacy of an oral vaccinia-rabies glycoprotein recombinant vaccine in controlling epidemic raccoon rabies in New Jersey J Wildl Dis 34 1998 752 763
4. M.P. Moraes, J. Chinsangaram, M.C. Brum, and M.J. Grubman Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine Vaccine 22 2003 268 279
5. J. Hahn, S.H. Park, J.Y. Song, S.H. An, and B.Y. Ahn Construction of recombinant swinepox viruses and expression of the classical swine fever virus E2 protein J Virol Methods 93 2001 49 56
6. L. Siger, R.A. Bowen, K. Karaca, M.J. Murray, P.W. Gordy, and S.M. Loosmore Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses Am J Vet Res 65 2004 1459 1462
7. D.E. Swayne, M. Garcia, J.R. Beck, N. Kinney, and D.L. Suarez Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert Vaccine 18 2000 1088 1095
8. J.T. van Oirschot, M.J. Kaashoek, F.A.M. Rijsewijk, and J.A. Stegemen The use of marker vaccines in eradication of herpesviruses J Biotechnol 44 1996 75 81
9. rns of the pestivirus classical swine fever virus lead to virus attenuation J Virol 73 1999 10224 10235
10. Avian Influenza (H5 and H7 Subtypes) Vaccine Bank. USDA/APHIS/VS/ Center for Veterinary Biologics Notice No. 04-12; June 3, 2004.
11. I. Capua, C. Terregino, G. Cattoli, F. Mutinelli, and J.F. Rodriquez Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza Avian Pathol 32 2003 47 55
12. B.S. Davis, G.J. Chang, B. Cropp, J.T. Roehrig, D.A. Martin, and C.J. Mitchell West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays J Virol 75 2001 4040 4047
13. Y.W. Wang, T.Y. Chang, A.M. Walfield, J. Ye, M. Shen, and M.L. Zhang Synthetic peptide-based vaccine and diagnostic system for effective control of FMD Biologicals 29 2001 221 228
14. ® Pesti in pregnant sows Vet Microbiol 77 2000 83 97
15. M.J. Dus Santos, A. Wigdorovitz, K. Trono, R.D. Rios, P.M. Franzone, and F. Gil A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants Vaccine 20 2002 1141 1147
16. C.W. Lee, D.A. Senne, and D.L. Suarez Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza Vaccine 22 2004 3175 3181